Jump to Navigation | Jump to Content
 
  |  Join ABA  |  Media  |  Contact
Advanced Search
Topics A-Z
 
Print This  | Page Feedback

ABA Section of Litigation
Products Liability
 

Welcome to the Products Liability website! We are an open, friendly and diverse Committee, combining lawyers of all ages and backgrounds, who come from around the country and work in different practice settings. We are not so large that you will feel lost in the crowd; and large enough with enthusiasm to spare to mount significant CLE programs and other member benefits.


If you have an interest in national, regional or local program planning, publishing articles about the law, creating online columns or CLE, and would like to work with a highly collegial and diverse group of lawyers with interests in products liability law and practice, then you've come to the right Committee!


UPCOMING EVENTS

Regional CLE Workshop: Current Issues in Pharmaceutical and Medical Device Litigation
November 12, 2009
Schering-Plough, Kenilworth, NJ
» Register Now

Joint Committees CLE Seminar
January 28–30, 2010
Park Hyatt Beaver Creek Resort & Spa | Avon, CO


RECENT UPDATES
The Medical Device Safety Act of 2009

Congressional committees are considering a bill that would amend the Federal Food, Drug, and Cosmetic Act (FDCA) with respect to liability under state and local requirements respecting medical devices.


Tips for Examining Life Care Planners and Economists(Young Lawyers’ Practice Tips)

In catastrophic personal injury cases, plaintiffs rely on the expert testimony of life care planners and economists to support their claim for damages.


Products Liability Newsletter: Spring 2009

The Spring 2009 edition of the Products Liability newsletter is now available.


Wyeth v. Levine

On March 4, 2009, the United States Supreme Court issued its long-awaited opinion in Wyeth v. Levine.  This case was the most recent in the ongoing debate over federal preemption in the area of pharmaceutical and medical device products.  Here, Wyeth presented a fundamental issue: does Food and Drug Administration (FDA) approval of a drug’s label preempt common law tort claims?  By a 6-3 vote, the Supreme Court held that FDA approval of a drug label does not preempt state law tort claims.


 
Inside this Committee
 

Committee Leadership

Co-Chairs

Jerry G. Bradford

Forth Worth, TX


Nathaniel Cade, Jr.

Milwaukee, WI


Daniel S. Wittenberg

Denver, CO


Web Editors

Richard Gaal

Mobile, AL


Brian D. Fowler

Richmond, VA


Newsletter Editors

James Rotondo

Hartford, CT


Prof. James O’Reilly

Cincinnati, OH


 

 
 

Back to Top

Copyright American Bar Association. http://www.abanet.org